Gonzalez, R.D.; Small, G.W.; Green, A.J.; Akhtari, F.S.; Motsinger-Reif, A.A.; Quintanilha, J.C.F.; Havener, T.M.; Reif, D.M.; McLeod, H.L.; Wiltshire, T.
MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients. Pharmaceuticals 2023, 16, 757.
https://doi.org/10.3390/ph16050757
AMA Style
Gonzalez RD, Small GW, Green AJ, Akhtari FS, Motsinger-Reif AA, Quintanilha JCF, Havener TM, Reif DM, McLeod HL, Wiltshire T.
MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients. Pharmaceuticals. 2023; 16(5):757.
https://doi.org/10.3390/ph16050757
Chicago/Turabian Style
Gonzalez, Ricardo D., George W. Small, Adrian J. Green, Farida S. Akhtari, Alison A. Motsinger-Reif, Julia C. F. Quintanilha, Tammy M. Havener, David M. Reif, Howard L. McLeod, and Tim Wiltshire.
2023. "MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients" Pharmaceuticals 16, no. 5: 757.
https://doi.org/10.3390/ph16050757
APA Style
Gonzalez, R. D., Small, G. W., Green, A. J., Akhtari, F. S., Motsinger-Reif, A. A., Quintanilha, J. C. F., Havener, T. M., Reif, D. M., McLeod, H. L., & Wiltshire, T.
(2023). MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients. Pharmaceuticals, 16(5), 757.
https://doi.org/10.3390/ph16050757